Why are you so obsessed with a very early stage deal not having been done?
With hundreds or more companies in the oncology space, why do you think a BP would move to sign a licensing deal early when they can wait until a later stage?
Why do you think an early low value deal would be preferable to IMU shareholders over a later deal/TO on more favourable terms?
IMU Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)